| March 8, 2004 | ||||||||||
In Print![]() Photo by Leah Gourley
From Focus: Minocycline, an old-line antibiotic, has been shown to prevent the programmed cell death and scarring associated with spinal cord injuries. But how it does this has been unclear. Now, Yang Teng (left), Robert Friedlander (right), Howard Choi, and their colleagues report that the drug works by preventing certain organelles in nerve cells from releasing the well-known cell death messenger cytochrome c. By tracking how soon after injury cytochrome c is released, and at what rate, the researchers designed a regimen that preserved tissue and function in spinal cord injured rats.
|
|
HeadlinesBiochemical Clues to Long Lifespan Revealed
UpcomingEcological Design of Buildings and Communities
Joachim Eble, Principal, Joachim Eble Architektur
Lab WorksA multimedia site featuring Harvard Medical research |
Spotlight
Student Scene
|
|||||||
Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home |